Narcolepsy Marketis expected to grow at 7.45% through 2030F
The increasing prevalence of
narcolepsy is expected to drive the growth of Global Narcolepsy Market during
the forecast period, 2026-2030F.
According to TechSci Research report, “Narcolepsy
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F”, Global Narcolepsy Market was valued at USD 3.43 billion in 2024 and is expected to reach USD 5.24 billion by 2030 with a CAGR of 7.45%. This can be ascribed to the
increasing obese population and the growing prevalence of narcolepsy among
young populations across the globe. The increasing disposable incomes and
greater government spending on healthcare systems in the developing region,
especially in North America and Europe are expected to create lucrative
opportunities for narcolepsy market growth in the coming years. Furthermore,
the growing development of new narcolepsy drugs for easy diagnosis and
treatment of sleep disorders and previous brain disorders from the family is
expected to drive the market growth during the forecast period. Similarly,
increasing adoption of newly developed narcolepsy treatments among the
population and research and development that improved the quality of drugs will
help in treatment and is expected to drive the market growth during the
forecast period. The collaboration with fewer known players could help
prominent players which in expanding their market presence and increasing their
revenue during the forecast period.
However, side effects associated
with narcolepsy drugs and issues concerning around misdiagnosis slow down the
growth of the global narcolepsy market during the forecast period. The lack of awareness about new narcolepsy drugs for the treatment of sleep
disorders in emerging countries can further restrict the growth of the global
narcolepsy market. Similarly, the high cost and diagnosis and treatment for
narcolepsy can further restrict the growth of the market during the forecast
period.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "Global Narcolepsy Market"
The global narcolepsy market can be segmented on the type, diagnosis, treatment, end user, and region.
Based on end users, the market can
be segmented into hospitals, clinics, retail pharmacies, and
others. The hospitals segment is expected to fastest growing segment during
the forecast period on account of the increase in narcolepsy to diagnose
patients using polysomnography along with multiple sleep latency tests and
other diagnostic tests. Similarly, different local, national and international
institutions and organizations have taken an initiative to provide relevant
information regarding available narcolepsy treatment options which will further
boost the market growth during the forecast period.
Based on region, the Asia-Pacific
region is the fastest-growing market for narcolepsy treatments due to several
key factors. Increasing awareness and improving diagnostic
capabilities in countries like China, Japan, India, and South Korea are driving
more accurate identification of narcolepsy cases. Historically, underdiagnosis
was common in the region due to limited access to specialized sleep clinics and
lack of public awareness, but this is changing rapidly with expanding
healthcare infrastructure. Rising healthcare expenditure and
government initiatives to improve sleep disorder diagnosis and management
contribute to market growth. Many countries in the region are investing in
healthcare modernization, making advanced diagnostic tools and innovative
therapies more accessible. The growing prevalence of sleep disorders,
partly linked to urbanization, high stress levels, and lifestyle changes, is
increasing the patient population seeking treatment. As more patients are
diagnosed, demand for effective and convenient treatments rises. The presence
of expanding pharmaceutical markets and growing interest from global and local
drug manufacturers in Asia-Pacific encourages development and introduction of
novel narcolepsy therapies. This, combined with improving reimbursement
policies and rising disposable incomes, facilitates better patient access. These
factors collectively position Asia-Pacific as a dynamic and fast-growing region
in the global narcolepsy market, with significant untapped potential and
expanding opportunities.
Major companies operating in the
global narcolepsy market are:
·
Jazz
Pharmaceuticals Plc.
·
Bioprojet.
·
Arena
Pharmaceuticals, Inc.
·
Graymark
Healthcare, Inc.
·
Mylan N.V.
·
Teva
Pharmaceutical Industries Ltd.
·
Novartis AG.
·
Shire
·
Shionogi Inc.
·
Ligand
Pharmaceuticals, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“North America was expected to
dominate in the Global Narcolepsy Market owing to the growing prevalence of
narcoleptic disorders such as obstructive sleep apnea, restless legs syndrome,
and insomnia across the region. Similarly, growing healthcare initiatives and
awareness campaigns taken by government organizations in order to educate
people and healthcare professionals about sleep disorders and new diagnoses is
further expected boost the growth of the market during the forecast period.
Furthermore, depression and anxiety-related symptoms among the young population
are anticipated to drive the growth of the market over the years. Besides, the
growing number of new companies in the market and technological advancements in
the development of new drugs for the treatment of sleep disorder and growing
approval of new drugs and their successful commercialization in the market is
further expected to create lucrative opportunities for market growth,” said Mr.
Karan Chechi, Research Director of TechSci Research, a research-based global
management consulting firm.
“Narcolepsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type (Type 1, Type 2, Others), By Diagnosis (Polysomnogram, Multiple Sleep Latency Test, Others), By Treatment (Stimulants, Antidepressants, Sodium Oxybate, Others), By End User (Hospitals, Clinics, Retail Pharmacies, Others), By Region & Competition 2020-2030F”, has
evaluated the future growth potential of global narcolepsy market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision-makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in the Global Narcolepsy Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite
300,
New York, United States-
10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com